Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,791.60
(
0.00%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
105.39
(
1.16%
)
Bitcoin
80,714.01
(
-0.42%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TastyTheElf

Send PM Follow Ignore
Followers 75
Posts 7730
Boards Moderated 0
Alias Born 05/01/2011

TastyTheElf

Re: DewDiligence post# 127064

Wednesday, 09/21/2011 9:34:45 PM

Wednesday, September 21, 2011 9:34:45 PM

Post# of 257566
what makes the MNTA-Amphastar case unusual is that one generic-drug company is suing another.

OK, here comes another naive question... how can there be a patent enfringement in a generics case? What can a company do to infringe on patents when patent protection on the original drug has expired?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today